← Open Payments lookup

JOHN-PAUL GOMEZ: Open Payments

NPI 1811958366 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$465 in 23 payments from 9 companies in 2025. Trend: 2023 $448 · 2024 $709 · 2025 $465

Food & beverage: $465
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$141
Neurocrine BioSciences, Inc.2$101
Teva Pharmaceuticals USA, Inc.5$95
Janssen Pharmaceuticals, Inc2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Otsuka America Pharmaceutical, Inc.1$19
Vanda Pharmaceuticals Inc.1$19
Lundbeck LLC1$18
Alkermes, Inc.1$14

Products named: COBENFY, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, UZEDY, CAPLYTA, ABILIFY ASIMTUFII, FANAPT.

Industry payments across PA — which companies pay providers there.